James W. Malecha - San Diego CA, US Sergio G. Duron - San Diego CA, US Andrew K. Lindstrom - Encinitas CA, US
Assignee:
Kalypsys Inc. - San Diego CA
International Classification:
A61K 31/4965 C07D 241/04
US Classification:
51425502, 51425503, 544383, 544392, 544403
Abstract:
Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
Sulfonyl-Substituted Bicyclic Compounds As Modulators Of Ppar
Stewart A. Noble - San Diego CA, US Guy Oshiro - San Diego CA, US James W. Malecha - San Diego CA, US Cunxiang Zhao - San Diego CA, US Carmen Robinson - San Diego CA, US Sergio G. Duron - San Diego CA, US Michael Sertic - Del Mar CA, US Andrew K. Lindstrom - Encinitas CA, US Andrew K. Shiau - San Diego CA, US Christopher D Bayne - Honolulu HI, US Mehmet Kahraman - San Diego CA, US Boliang Lou - Louisville KY, US Steven P. Govek - San Diego CA, US
Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
Sulfonyl-Substituted Bicyclic Compounds As Modulators Of Ppar
Stewart A. Noble - San Diego CA, US Guy Oshiro - San Diego CA, US James W. Malecha - San Diego CA, US Cunxiang Zhao - San Diego CA, US Carmen K. Robinson - San Diego CA, US Sergio G. Duron - San Diego CA, US Michael Sertic - San Diego CA, US Andrew K. Lindstrom - Endinitas CA, US Andrew K. Shiau - San Diego CA, US Christopher D. Bayne - Honolulu HI, US Mehmet Kahraman - San Diego CA, US Boliang Lou - Louisville KY, US Steve P. Govek - San Diego CA, US
Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
Controlled Release Ion Channel Modulator Compositions And Methods For The Treatment Of Otic Disorders
Jay Lichter - Rancho Santa Fe CA, US Benedikt Vollrath - San Diego CA, US Sergio G. Duron - San Diego CA, US Carl Lebel - Malibu CA, US Fabrice Piu - San Diego CA, US Qiang Ye - San Diego CA, US Luis A. Dellamary - San Marcos CA, US Andrew M. Trammel - Olathe KS, US Michael Christopher Scaife - Los Altos CA, US Jeffrey P. Harris - La Jolla CA, US
Assignee:
Otonomy, Inc. - San Diego CA The Regents of The University of California - Oakland CA
International Classification:
A61K 9/14
US Classification:
424484
Abstract:
Disclosed herein are compositions and methods for the treatment of otic disorders with ion channel modulators. In these methods, the ion channel modulator compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the ion channel modulator compositions and formulations onto the auris interna target areas, or via perfusion into the auris interna structures.
Controlled Release Auris Sensory Cell Modulator Compositions And Methods For The Treatment Of Otic Disorders
Jay Lichter - Rancho Santa Fe CA, US Benedikt Vollrath - San Diego CA, US Sergio G. Duron - San Diego CA, US Carl Lebel - Malibu CA, US Fabrice Piu - San Diego CA, US Qiang Ye - San Diego CA, US Luis A. Dellamary - San Marcos CA, US Andrew M. Trammel - Olathe KS, US Michael Christopher Scaife - Los Altos CA, US Jeffrey P. Harris - La Jolla CA, US
Assignee:
Otonomy, Inc - San Diego CA The Regents of the University of California - Oakland CA
International Classification:
A61K 9/14 A61K 31/47 A61K 31/517
US Classification:
424437, 424489, 5142661, 514312, 514646
Abstract:
Disclosed herein are methods for the treatment of otic diseases or conditions with intratympanic compositions and formulations of multiparticulate auris sensory cell modulating agent administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Novel Compounds, Compositions And Uses Thereof For Treatment Of Metabolic Disorders And Related Conditions
James Malecha - San Diego CA, US Cunxiang Zhao - San Diego CA, US Carmen Robinson - San Diego CA, US Sergio Duron - San Diego CA, US Michael Sertic - Del Mar CA, US Stewart Noble - San Diego CA, US
Assignee:
Kalypsys, Inc. - San Diego CA
International Classification:
A61K031/427 C07D417/02
US Classification:
514365000, 548181000
Abstract:
Described herein are novel mono- and bicyclic compounds compounds, including compounds capable of modulating the activity of human peroxisome proliferator activated receptor of the subtype delta (hPPAR-delta), and methods for utilizing such modulation to treat a disease or condition mediated or impacted by hPPAR-delta activity such as Type 2 diabetes, syndrome X, dyslipidemia, and atherosclerotic diseases including vascular disease, coronary heart disease, cerebrovascular disease, and peripheral vessel disease. Also described are compounds that mediate and/or inhibit the activity of hPPAR-delta, and pharmaceutical compositions containing such compounds or pharmaceutically acceptable prodrugs, solvates, salts, esters, thioesters, or amides or pharmaceutically active metabolites thereof. Further described are methods for making and producing such compounds. Also described are the therapeutic or prophylactic use of such compounds or compositions, and methods of treating metabolic disorders and conditions, by administering effective amounts of such compounds.
Aryl Sulfonamide And Sulfonyl Compounds As Modulators Of Ppar And Methods Of Treating Metabolic Disorders
Cunxiang Zhao - San Diego CA, US James Malecha - San Diego CA, US Stewart Noble - San Diego CA, US Sergio Duron - San Diego CA, US Andrew Lindstrom - San Diego CA, US Andrew Shiau - San Diego CA, US
Aryl sulfonamide and sulfonyl compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
Sulfonyl-Substituted Bicyclic Compounds As Modulators Of Ppar
Stewart Noble - San Diego CA, US Guy Oshiro - San Diego CA, US James Malecha - San Diego CA, US Cunxiang Zhao - San Diego CA, US Carmen Robinson - San Diego CA, US Sergio Duron - San Diego CA, US Michael Sertic - Del Mar CA, US Andrew Lindstrom - Encinitas CA, US Andrew Shiau - San Diego CA, US Christopher Bayne - Honolulu HI, US Mehmet Kahraman - San Diego CA, US Boliang Lou - Louisville KY, US Steven Govek - San Diego CA, US
Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
Calporta Therapeutics
Chief Strategy Officer
Afraxis, Inc Jun 2008 - Jan 2014
Vice President, Chemistry
Zacharon Pharmaceuticals Jan 2009 - Jan 2013
Director, Medicinal Chemistry
Sova Pharmaceuticals, Inc. Jan 2009 - Jan 2013
Vice President, Chemistry and Drug Discovery at Sova Pharmaceuticals and Coi Pharmaceuticals
Kalypsys 2003 - 2008
Principal Scientist
Education:
University of Illinois at Urbana - Champaign 1996 - 2002
Doctorates, Doctor of Philosophy, Organic Chemistry
The University of Texas at Austin 1990 - 1995
Bachelors, Bachelor of Science, Chemistry
Skills:
Drug Discovery Medicinal Chemistry Chemistry Biotechnology Organic Chemistry Pharmaceutical Industry Organic Synthesis Drug Design Lifesciences Lead Change Hplc Synthetic Organic Chemistry Parallel Synthesis Heterocyclic Chemistry Combinatorial Chemistry High Throughput Screening Computational Chemistry Peptide Synthesis